A recent survey highlighted a widespread lack of understanding about the much-publicised GLP-1 weight-loss medications ...

Weight loss jabs will not be enough to make “lasting progress” on tackling the obesity epidemic, leading medics have said.

Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

Weight loss injections will not be enough to make “lasting progress” in tackling the obesity epidemic, leading medical experts have warned.

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...

Focusing solely on achieving weight loss for people with a high body mass index (BMI) may do more harm than good, argue ...

The researchers found health perks directly linked with weight loss through blood test results, including increases in HDL ...

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk and potential applications for addiction treatment.

Feeling less stigma — not losing weight — was linked to better mental health and eating behaviors after bariatric surgery.

Research shows morning workouts may be optimal for weight loss and mental health, though experts stress that quality sleep ...

A new study found that weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting compared to clinical trials.

Alternatives to weekly injections of weight-loss drugs may be on the way. A monthly dose of a new drug called MariTide helped ...